Eutilex

About:

Eutilex is a develops immunotherapy technology, anti tumor T cell therapy and antibody therapeutics, and other technology products.

Website: http://www.eutilex.com/

Top Investors: DS Asset Management, Kolon Investment, G.N. Tech Venture, SNU Bio Angel

Description:

Eutilex Co., Ltd. develops biotechnology. The Company develops immunotherapy technology, anti tumor T cell therapy and antibody therapeutics, and other technology products. Eutilex markets its products throughout South Korea.

Total Funding Amount:

21B KRW

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2015-01-01

Founders:

Byoung Kwon

Number of Employees:

51-100

Last Funding Date:

2016-12-08

IPO Status:

Private

Industries: